Journal of Pathology Clinical Research

Papers
(The TQCC of Journal of Pathology Clinical Research is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Issue Information76
Immune checkpoint CD161/LLT1‐associated immunological landscape and diagnostic value in oral squamous cell carcinoma46
Clinicopathological features and cancer transcriptomic profiling of poorly cohesive gastric carcinoma subtypes30
Clinical and molecular correlates of digitally quantified anthracosis in lung tissue slides: utility of an automated quantitative workflow29
A novel telomere biology disease‐associated gastritis identified through a whole exome sequencing‐driven approach28
The prognostic marker elastin correlates with epithelial–mesenchymal transition and vimentin‐positive fibroblasts in gastric cancer25
Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis24
Leveraging deep learning to discover interpretable cellular spatial biomarkers for prognostic predictions based on hepatocellular carcinoma histology24
Diffuse glioma with FGFR3‐TACC3 fusion in adults is not a homogenous clinicopathological and molecular entity24
Issue Information23
Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements22
SOX10 distinguishes oligodendrogliomas from low‐grade glioneuronal tumors/low‐grade gliomas with oligodendrocyte‐like features21
KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K/AKT signaling pathway21
MET ‐amplified gastric cancers exhibit co‐amplifications of BRAF20
Authors' reply: Re: Koga et al. Retrieval‐augmented generation versus document‐grounded generation: a key distinction in large language models19
19
Somatic whole exome sequencing of colorectal carcinoma in young patients from sub‐Saharan Africa reveals novel insights18
17
Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer16
MET fusions and splicing variants in glioma: a landscape integrating clinical, pathological, and survival features16
Authors' reply: Re: Yang et al . The road to therapy for myeloid sarcoma: navigating the complexities of subclonal MAPK 16
Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study14
Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite‐instable colorectal cancers14
KRAS mutations and endometriosis burden of disease13
Immune checkpoint profiling of B7 ‐H proteins predicts survival and treatment response in metastatic clear cell renal cell carcinoma13
Altered cytoplasmic and nuclear ADP‐ribosylation levels analyzed with an improved ADP‐ribose binder are a prognostic factor in renal cell carcinoma12
11
Validation of fibroblast activation protein and α‐smooth muscle actin as prognostic biomarkers in prostate cancer through AI ‐assisted image analysis11
Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis11
Dual epigenetic changes in diabetes mellitus‐associated pancreatic ductal adenocarcinoma correlate with downregulation of E‐cadherin and worsened prognosis11
Engineering the future of 3D pathology10
Issue Information10
Issue Information10
10
Low‐burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation10
Real‐life data from standardized preanalytical coding (SPREC) in tissue biobanking and its dual use for sample characterization and process optimization10
Issue Information10
Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression9
Validation of a whole slide image management system for metabolic‐associated steatohepatitis for clinical trials9
ATM immunohistochemistry as an effective screening method for POLE 9
Clinicopathologic and molecular landscape of villitis of unknown etiology: insights from a large‐scale case–control study in PR China9
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study9
Cancer‐associated fibroblasts are associated with CD8 + T cell depletion and poor prognosis in colorectal adenocarcinoma: a multi‐omics and machine l9
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer8
pTDP‐43 aggregates accumulate in non‐central nervous system tissues prior to symptom onset in amyotrophic lateral sclerosis: a case series linking archival surgical biopsies with clinical p8
Issue Information8
Prognostic significance of beta‐adrenergic receptor expression in oesophageal adenocarcinoma8
A prognostic six‐gene expression risk‐score derived from proteomic profiling of the metastatic colorectal cancer secretome8
8
Oestrogen receptor phosphorylation profiles and in silico PAM50 subtyping reflect sexual dimorphism in breast cancer8
Exosome‐derived ANXA9 functions as an oncogene in breast cancer7
Folate receptor alpha ( FRα ) expression in tubo‐ovarian and endometrial tumors: a study of 923 cases7
First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma7
Preservation of cell‐free RNA in percutaneous core‐needle biopsy specimens' supernatants from non‐small cell lung cancer improves genomic testing per7
Tumor‐type–specific expression of TTF ‐1 in primary central nervous system tumors classified by the 2021 WHO 7
Inter‐rater agreement of HER2 ‐low scores between expert breast pathologists and the Visiopharm digital image analysis application ( 7
MMR deficiency is frequent in colorectal carcinomas with diffuse SLFN11 immunostaining: clinicopathologic and molecular study of 31 cases identified among 3,300 tumors7
Weakly supervised deep learning for cutaneous squamous and basal cell carcinoma in whole‐slide histopathology7
Hyaluronan accumulation is associated with reduced hyaluronidase expression in renal cell carcinoma, with CD44, HAS1, and HYAL2 emerging as prognostic markers6
HISTAI : a valuable dataset with a valuable lesson6
Sarcomatoid areas of urothelial carcinoma are enriched for CD163‐positive antigen‐presenting cells6
Oncocytic and spindle cell typical carcinoids of lung: different immunophenotype and biological behavior6
Reduced GATA3 expression associates with immuno‐metabolic alterations and aggressive features in breast cancer6
Closing the loop – the role of pathologists in digital and computational pathology research6
DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell‐rich histological mimics6
Accounting for intensity variation in image analysis of large‐scale multiplexed clinical trial datasets6
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors6
0.082507133483887